BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23490554)

  • 1. Serological responses after vaccination of growing pigs with foot-and-mouth disease trivalent (type O, A and Asia1) vaccine.
    Lee HS; Lee NH; Seo MG; Ko YJ; Kim B; Lee JB; Kim JS; Park S; Shin YK
    Vet Microbiol; 2013 Jun; 164(3-4):239-45. PubMed ID: 23490554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of optimal age for single vaccination of growing pigs with foot-and-mouth disease bivalent vaccine in South Korea.
    Kim AY; Tark D; Kim H; Kim JS; Lee JM; Kwon M; Bae S; Kim B; Ko YJ
    J Vet Med Sci; 2017 Nov; 79(11):1822-1825. PubMed ID: 28943596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient protection against Asia1 type foot-and-mouth disease using a chimeric vaccine strain suitable for East Asia.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Hwang SY; Jo H; Kim HM; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2021 Feb; 253():108975. PubMed ID: 33418393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased humoral antibody response of foot-and-mouth disease virus vaccine in growing pigs pre-treated with poly-γ-glutamic acid.
    Lee JH; Kang IJ; Kim AR; Noh YS; Chung HC; Park BK
    J Vet Sci; 2016 Jun; 17(2):253-6. PubMed ID: 26645341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge.
    Chen SP; Lee MC; Sun YF; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR; Ellis TM
    Vaccine; 2007 May; 25(22):4464-9. PubMed ID: 17445957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a high quality O
    Galdo Novo S; Malirat V; Maradei ED; Pedemonte AR; Espinoza AM; Smitsaart E; Lee KN; Park JH; Bergmann IE
    Vaccine; 2018 Mar; 36(12):1570-1576. PubMed ID: 29472132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014-2015.
    Jo HE; Ko MK; Choi JH; Shin SH; Jo H; You SH; Lee MJ; Kim SM; Kim B; Park JH
    J Vet Sci; 2019 Jul; 20(4):e42. PubMed ID: 31364326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of type O foot-and-mouth disease by vaccination in Korea, 2014-2015.
    Park JH; Tark D; Lee KN; Chun JE; Lee HS; Ko YJ; Kye SJ; Kim YJ; Oem JK; Ryoo S; Lim SB; Lee SY; Choi JH; Ko MK; You SH; Lee MH; Kim B
    J Vet Sci; 2018 Mar; 19(2):271-279. PubMed ID: 29169228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
    Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
    Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge.
    Jung M; Park HT; Park JH; Lee KN; Shin SW; Shin MK; Sung KY; Jung YK; Kim B; Yoo HS
    Immunol Invest; 2015; 44(1):101-12. PubMed ID: 25058651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
    Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
    Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic properties of a novel vaccine strain for type Asia1 foot-and-mouth disease in pigs.
    Shin SH; Jo H; Ko MK; Choi JH; You SH; Jo HE; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2020 Sep; 248():108802. PubMed ID: 32827925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs.
    Hwang JH; Lee KN; Kim SM; Lee G; Moon Y; Kim B; Lee JS; Park JH
    J Vet Sci; 2019 May; 20(3):e29. PubMed ID: 31161747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental infections using the foot-and-mouth disease virus O/JPN/2010 in animals administered a vaccine preserved for emergency use in Japan.
    Fukai K; Nishi T; Shimada N; Morioka K; Yamada M; Yoshida K; Sakamoto K; Kitano R; Yamazoe R; Yamakawa M
    J Vet Med Sci; 2017 Jan; 79(1):128-136. PubMed ID: 27773883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postvaccination serosurveillance of foot-and-mouth disease through virus-neutralizing and nonstructural protein antibody tests on pig farms in Taiwan: 2009-2020.
    Lee MC; Sun YF; Deng MC; Lin NN; Hsu JP; Chiou CJ; Tu WJ; Chen SP
    Prev Vet Med; 2024 Jun; 227():106197. PubMed ID: 38613943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of swine protection with foot-and-mouth disease O
    Choi J; Jo HJ; Jung SS; Choi J; Lee SH; Kim HH; Kim YJ; Kim B; Park JH; Kim J
    Vaccine; 2021 Mar; 39(12):1701-1707. PubMed ID: 33618945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig.
    Kim T; Hong JK; Oem JK; Lee KN; Lee HS; Kim YJ; Ryoo S; Ko YJ; Park JH; Choi J; Lee SH; Jo HJ; Lee MH; Kim B; Kim J
    Vaccine; 2019 Mar; 37(12):1702-1709. PubMed ID: 30712811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
    Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
    Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination.
    Nagendrakumar SB; Hong NT; Geoffrey FT; Jacqueline MM; Andrew D; Michelle G; Van Phuc K; Ngon QV; Phuong le TT; Phuc NN; Hanh TX; Van Hung V; Quynhanh le T; Tan TM; Long NT; Wilna V
    Vaccine; 2015 Aug; 33(36):4513-9. PubMed ID: 26192355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.